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Abstract
Background and purpose—Most of the neuropathological studies in brain aging were based on
the assumption of a symmetric right-left hemisphere distribution of both Alzheimer's disease (AD)
and vascular pathology. To explore the impact of asymmetric lesion formation on cognition, we
performed a clinicopathological analysis of 153 cases with mixed pathology except macroinfarcts.
Methods—Cognitive status was assessed prospectively using the Clinical Dementia Rating (CDR)
scale; neuropathological evaluation included assessment of Braak neurofibrillary tangle (NFT) and
Aß-deposition staging, microvascular pathology and lacunes. The right-left hemisphere differences
in neuropathological scores were evaluated using the Wilcoxon signed rank test. The relationship
between the interhemispheric distribution of lesions and CDR scores was assessed using ordered
logistic regression.
Results—Unlike Braak NFT and Aß deposition staging, vascular scores were significantly higher
in the left hemisphere for all CDR scores. A negative relationship was found between Braak NFT,
but not Aß, staging and vascular scores in cases with moderate to severe dementia. In both
hemispheres, Braak NFT staging was the main determinant of cognitive decline followed by vascular
scores and Aß deposition staging. The concomitant predominance of AD and vascular pathology in
the right hemisphere was associated with significantly higher CDR scores.
Conclusions—Our data show that the cognitive impact of AD and vascular lesions in mixed cases
may be assessed unilaterally without major information loss. However, interhemispheric differences
and, in particular, increased vascular and AD burden in the right hemisphere may increase the risk
for dementia in this group.
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Introduction
Several clinicopathological studies postulated that the presence of cortical microinfarcts or
lacunar infarcts significantly increase the risk for dementia among individuals with AD
lesions1-5. The vascular burden in brain aging may, however, influence the extent of AD
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pathology without having a cognitive impact per se6. We recently reported that cortical
microinfarcts and lacunes explained 15% of the presence of dementia in mixed cases without
macroinfarcts and with various degrees of AD pathology7. One main limitation of this latter
study was related to the use of a global bilateral microvascular score and assessment of AD
pathology limited to the right hemisphere. We assess here the interhemispheric differences in
AD and vascular lesion severity, relationships between AD and vascular burden in each
hemisphere as well as possible cognitive impact of asymmetric lesion distribution in an
independent series of prospectively studied patients with mixed pathology.
Materials and Methods
Patients
The initial autopsy series included 1875 patients who died and were autopsied at the Geriatric
and Psychiatric Hospitals of the University of Geneva during the period 1993-2006 (mean
death rates: 7.5% and 1% respectively). All of the patients were referred to the hospital from
the Geneva area and were older than 65 years of age. Permission for autopsy was systematically
requested as part of the routine clinical work in both hospitals. Four criteria were used to define
our sample. First, cases with other central nervous system disorders (i.e., tumors, inflammation,
Parkinson's disease, Lewy body disease) were excluded from the present study (n = 194).
Second, all cases with macroscopic infarcts or non AD-related pathology were also excluded
from the present series (n = 421). Similarly, cases with past history of psychiatric illnesses
were not considered (n = 44). From the remaining 1216 cases, the final series included 153
right-handed patients aged 73 to 101 years assessed with the Clinical Dementia Rating Scale
(CDR) at most three months prior to death (excluding cases with agonal states)8.(Table 1).
Tissue processing
Lacunes in the white matter or basal ganglia and thalamus, were identified on macroscopic
examination and controlled on Luxol-van Gieson (LVG) stained coronal sections. To visualize
cortical microinfarcts as well as focal cortical and white matter gliosis, 1-cm-thick tissue blocks
from the anterior hippocampus, inferior temporal, frontal, and parietal cortex bilaterally were
cut into 20-μm-thick serial sections and stained with Globus silver impregnation7. To assess
diffuse white matter and periventricular demyelination, 20-μm-thick sections at the level of
anterior commissure were stained with LVG. Additional 12-μm-thick sections were processed
bilaterally with antibodies to the tau and core amyloid ß proteins, α-synuclein and ubiquitin7.
All cases were classified neuropathologically according to the Braak NFT staging system9and
amyloid nomenclature10. Lacunes, cortical microinfarcts and focal cortical gliosis were
assessed in 10 sections per area using the following score: 0 (absence of such lesions), 1 (< 3
lesions per slide), 2 (3-5 lesions per slide), 3 (> 5 lesions per slide). Assessment of white matter
gliosis, diffuse white matter and periventricular demyelination in each hemisphere was made
using a similar rating scale: 0 = absent, 1 = mild, 2 = moderate, 3 = severe. For each of these
lesions, a mean score by area was calculated based on the ten sections. Subsequently, a mean
score by hemisphere was obtained for each lesion (sum of the mean scores/ number of areas).
A total vascular score by hemisphere was calculated by adding the total scores for the six lesions
considered (with a maximum score of 18 for each case).
Statistical analysis
The interhemispheric relationships between Braak NFT, Aß deposition staging and vascular
scores were assessed using the Wilcoxon signed rank test and Spearman correlation
coefficients. A possible age effect on the relationships between AD and vascular lesions in
demented cases was investigated by linear regression. Maximal likelihood ordered logistic
regression models with CDR scores (independent variable), and Braak NFT, Aß deposition
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staging, vascular scores, age (dependent variables) were built. Logistic regression analysis with
repeated measure design including the hemispheric side predominance was also performed
(306 observations for 153 subjects).
Results
There were strong positive relationships between the left and right Braak NFT staging (rs =
0.93, p < 0.0001; Fig. 1A), Aß deposition staging (rs= 0.89, p < 0.0001; Fig. 1B) and vascular
scores (rs= 0.74, p < 0.0001, Fig. 1C). These relationships were present across all CDR scores
(rs values ranging from 0.55 to 0.94, p < 0.05-0.0001). Unlike Braak NFT and Aß deposition
staging, a marked left predominance was observed for vascular scores (CDR 0: 10 L (left) vs
1 R (right) dominant; p < 0.01; CDR 0.5: 24 L vs 3 R dominant, p < 0.0005; CDR 1: 6 L vs 2
R dominant, p < 0.05; CDR 2: 22 L vs 6 R dominant, p < 0.001; CDR3: 28 L vs 9 R dominant,
p < 0.0005; Fig. 1D).
In both hemispheres, there was a positive association between Braak NFT and Aß deposition
staging in CDR 0.5 to 3 cases (rs= 0.47 to 0.59, p < 0.01-0.001) but not CDR 0 cases (Fig. 2).
In contrast, a negative relationship was found between Braak NFT staging and vascular scores
only in cases with moderate to severe dementia (CDR 2: rs= -0.29 L, p < 0.05, -0.53 R, p <
0.001; CDR3: rs= -0.41 L, p < 0.005, rs= -0.57 R, p < 0.0001). These CDR-dependent
relationships persisted after controlling for a possible age effect in multivariate models. No
significant relationships were found between Aß deposition staging and vascular scores in
either hemisphere (Fig. 2).
Braak NFT staging, Aß deposition staging and vascular scores were all significantly related to
CDR scores in the left hemisphere (12%, 4% and 4% of the CDR variability respectively).
Quasi-identical percentages were obtained in the right hemisphere. The concomitant
predominance of AD and vascular pathology in the right hemisphere was associated with
significantly higher CDR scores (odds ratio: 1.41, 95% confidence interval: {1.17, 1.71}, p <
0.001).
Discussion
In our mixed cases, NFT and Aß deposition populate the brain symmetrically even in very
early stages of neurodegeneration. In contrast, a left predominance of vascular lesions was
evident independently of the CDR score. Besides the work of Esiri et al. 11 in 6 demented
cases who postulated that the relevant microvascular damage in dementia is generally
symmetric, we are not aware of another neuropathological study addressing the lateralization
of vascular lesions in mixed cases. The increased vascular burden in the left hemisphere was
observed not only in demented but also in CDR 0 cases suggesting that it is mostly related to
normal brain aging and has no impact on cognitive deterioration.
The Aß deposition and Braak NFT staging were unrelated in cognitively intact cases but
showed a significant positive correlation not only in cases with clinically overt dementia but
also in CDR 0.5 cases (for review see 12). In the absence of a categorical definition of mild
cognitive impairment subgroups, this finding suggests that at least some of them could be very
mild AD cases. Unlike Aß deposition staging, our results partly support a synergistic effect of
NFT and 9 vascular lesions in mixed cases in that they reveal a weak yet significant negative
relationship between Braak NFT staging and vascular score in both hemispheres in cases with
moderate to severe dementia.
The percentage of CDR variability explained by each neuropathological parameter was nearly
identical in the two hemispheres implying that the assessment of vascular and AD pathology
in one hemisphere is sufficient to establish valid clinicopathological correlations in these mixed
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cases. However, the concomitant occurrence of higher AD pathology staging and vascular
scores in the right hemisphere is associated with increased CDR scores. This observation
parallels the earlier report of Reed and coworkers 13 in patients with lacunes. The predominant
development of vascular lesions in the left hemisphere may remain cognitively silent because
of a functional compensation assumed at least partly by the right hemisphere14. The invasion
of the right hemisphere by AD and vascular lesions would disrupt this phenomenon leading to
the expression of clinically overt dementia or increased dementia severity.
Several limitations should, however, be considered when interpreting our data. In order to focus
on brain aging, we did not made a categorical distinction between demented and non-demented
cases but also consider CDR 0.5 cases. This highly heterogeneous group includes cases with
mild cognitive impairment (amnestic or non amnestic, single domain or multidomain, vascular
or degenerative) but also cases with very mild dementia. Moreover, we did not include cases
with macroinfarcts that are thought to make a significant contribution at least in severe cases
of mixed dementia15. The clinical assessment was based on the CDR score that may not be
sensitive enough to the differences in interhemispheric relationships between lesions' severity
and cognitive deficits. Finally, the neuropathological assessment of microvascular lesions and
lacunes remains dependent on the sampling strategy used. Additional studies coupling imaging
data with neuropathological and neuropsychological observations in community-based series
are needed to further explore the differential interhemispheric vulnerability in patients with
mixed pathology.
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Scatterplots illustrating the relationship of Braak NFT staging (A), Aß deposition staging (B)
and vascular scores (C) between the two hemispheres (10% random noise was added to
discriminate each data couple). Note the strong bilateral correlation between the lesion severity
for all three neuropathological variables. Representative diagram of left versus right
hemispheric predominance for Braak NFT staging, Aß deposition staging and vascular scores
by CDR group (D). Note the consistent predominance of vascular lesions in left hemisphere.
No significant left-right differences were observed in respect to AD pathology.
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Scatterplots illustrating the relationship between Braak NFT staging (A-D), Aß deposition
staging (E-H) and vascular scores in the right hemisphere as a function of the CDR group (0,
0.5, 1, 2-3). Note the negative relationship between Braak NFT staging and vascular scores
observed in the CDR 2-3 group. See text for details.
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Table 1
Demographic data and CDR scores in the entire sample.
CDR Number of cases (W/M) Mean age years ± SEM
0 20 (13/7) 79.35 ± 2.12
0.5 31 (16/15) 84.48 ± 1.54
1 14 (7/7) 86.21 ± 1.48
2 35 (19/16) 88.31 ± 1.15
3 53 (36/17) 88.98 ± 0.87
All cases 153 (91/62) 86.40 ± 0.64
W, women; M, men. CDR, Clinical Dementia Rating score (0: no dementia, 0.5, questionable dementia, 1: mild dementia, 2: moderate dementia, 3: severe
dementia).
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